ImmuCell Corporation Increase (Decrease) in Other Accounts Payable and Accrued Liabilities
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Other Accounts Payable and Accrued Liabilities of $154.25 thousand for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-11-13.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities · last filed 2017-11-13
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-09-30 was $107.12K.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-06-30 was -$16.31K.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2017-03-31 was $63.44K, a 59.99% decline year-over-year.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for the quarter ending 2016-12-31 was $72.55K, a 216.58% increase year-over-year.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for fiscal 2016 was $7.54K, a 57.78% decline from fiscal 2015.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for fiscal 2015 was $17.87K.
- ImmuCell Corporation increase (decrease) in other accounts payable and accrued liabilities for fiscal 2014 was -$20.09K.
| Period end | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 3 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 6 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 9 month | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2017-09-30 | $107.12K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-13 | $90.81K derived: sum of 2 quarters · filed 2017-11-13 | $154.25K 10-Q · filed 2017-11-13 | $226.80K derived: sum of 4 quarters · filed 2017-11-13 |
| 2017-06-30 | -$16.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | $47.13K 10-Q · filed 2017-08-14 | $119.68K derived: sum of 3 quarters · filed 2017-08-14 | -$59.49K derived: sum of 4 quarters · filed 2017-08-14 |
| 2017-03-31 | $63.44K 10-Q · filed 2017-05-11 | $135.99K derived: sum of 2 quarters · filed 2017-05-11 | -$43.19K derived: sum of 3 quarters · filed 2017-05-11 | -$87.57K derived: sum of 4 quarters · filed 2017-05-11 |
| 2016-12-31 | $72.55K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$106.62K derived: sum of 2 quarters · filed 2017-03-30 | -$151.01K derived: sum of 3 quarters · filed 2017-03-30 | $7.54K 10-K · filed 2017-03-30 |
| 2016-09-30 | -$179.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$223.56K derived: sum of 2 quarters · filed 2016-11-10 | -$65.01K 10-Q · filed 2016-11-10 | -$42.09K derived: sum of 4 quarters · filed 2016-11-10 |
| 2016-06-30 | -$44.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $114.17K 10-Q · filed 2016-08-11 | $137.09K derived: sum of 3 quarters · filed 2016-08-11 | $171.99K derived: sum of 4 quarters · filed 2016-08-11 |
| 2016-03-31 | $158.55K 10-Q · filed 2016-05-11 | $181.47K derived: sum of 2 quarters · filed 2016-05-11 | $216.38K derived: sum of 3 quarters · filed 2016-05-11 | $195.15K derived: sum of 4 quarters · filed 2016-05-11 |
| 2015-12-31 | $22.92K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $57.83K derived: sum of 2 quarters · filed 2016-03-25 | $36.59K derived: sum of 3 quarters · filed 2016-03-25 | $17.87K 10-K · filed 2016-03-25 |
| 2015-09-30 | $34.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $13.68K derived: sum of 2 quarters · filed 2015-11-12 | -$5.05K 10-Q · filed 2015-11-12 | |
| 2015-06-30 | -$21.23K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-13 | -$39.96K 10-Q · filed 2015-08-13 | ||
| 2015-03-31 | -$18.73K 10-Q · filed 2015-05-12 | |||
| 2014-12-31 | -$20.09K 10-K · filed 2015-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |